生存素

Survivin expression is upregulated in many types of cancer cells, making it a potential therapeutic target.
生存素在多种类型的癌细胞中表达上调，使其成为潜在的治疗靶点。
The study demonstrated that survivin plays a crucial role in cell division and inhibition of apoptosis.
研究显示，生存素在细胞分裂和抑制细胞凋亡过程中发挥着关键作用。
Targeting survivin with specific inhibitors could enhance the efficacy of chemotherapy in patients.
使用特定抑制剂靶向生存素可能提高患者化疗效果。
Overexpression of survivin was found to be associated with poor prognosis in breast cancer patients.
发现生存素过表达与乳腺癌患者的不良预后相关。
Researchers have developed novel peptides that can suppress survivin activity, thereby promoting programmed cell death.
研究人员开发了新型肽类，能够抑制生存素活性，从而促进程序性细胞死亡。
Immunohistochemical analysis revealed strong survivin staining in the nucleus and cytoplasm of tumor cells.
免疫组化分析显示，在肿瘤细胞的细胞核和胞浆中有强烈的生存素染色。
Downregulation of survivin by siRNA technology resulted in decreased tumor growth and increased sensitivity to radiotherapy.
通过siRNA技术下调生存素表达导致肿瘤生长减少，并增加了对放射疗法的敏感性。
The level of survivin expression may serve as a biomarker for predicting patient response to certain treatments.
生存素表达水平可作为预测患者对某些治疗反应的生物标志物。
In vitro studies showed that survivin knockdown significantly inhibited proliferation and promoted apoptosis in leukemia cells.
体外研究表明，敲减生存素显著抑制白血病细胞增殖并促进其凋亡。
Recent findings suggest that survivin might also play an important part in regulating the immune response.
最近的研究发现，生存素也可能在调节免疫反应中起着重要作用。